Back to company

NORDIC HEALTH INNOVATIONS ApS: Financial statements 2024

CVR: 36506776

NORDIC HEALTH INNOVATIONS ApS (CVR 36506776) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 5,425,310 and a net result of DKK 879,317 compared with DKK 599,391 the year before. That is an increase of 16.8% compared with the year before. Equity amounted to DKK 748,751. The solvency ratio was 19.4%. The company had 4 employees in the financial year.

Gross Profit
5,425,310 kr.
Profit/Loss
879,317 kr.
Equity
748,751 kr.
Total Assets
3,867,892 kr.
Employees
4

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024-5.4 mio.879 t.749 t.4
2023-4.6 mio.599 t.-131 t.4
2022-5.3 mio.712 t.-730 t.4
2021-2.9 mio.230 t.-1.4 mio.2
2020-757 t.-245 t.-1.7 mio.2

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is NORDIC HEALTH INNOVATIONS ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2024

NORDIC HEALTH INNOVATIONS ApS: The 2023 annual report is outMay 15, 2024

NORDIC HEALTH INNOVATIONS ApS has published its annual report for 2023. Gross profit came to DKK 4,644,883, and the net result was DKK 599,391.

About NORDIC HEALTH INNOVATIONS ApS

NORDIC HEALTH INNOVATIONS ApS was a Danish company of the type Anpartsselskab based in Søborg, founded in 2015. The company was registered under the industry Andre informationsaktiviteter. The management consists of Adam Ali Holm Ghotbi. The company is owned by LM HOLDING ROSKILDE ApS, TOLSGAARD HOLDING ApS and ASG HOLDING 2014 ApS. In 2025, the company reported a gross profit of DKK 3,206,221 and a net result of DKK 242,639 compared with DKK 879,317 the year before. Equity amounted to DKK 991,390.